199796-52-6
中文名稱
DHA-PACLITAXEL
英文名稱
DHA-paclitaxel
CAS
199796-52-6
分子式
C69H81NO15
分子量
1164.38
MOL 文件
199796-52-6.mol
199796-52-6 結(jié)構(gòu)式
基本信息
英文別名
TaxoprexinTAXOPREXIN(P)
DHA-paclitaxel
Paclitaxel Impurity 98
Paclitaxel 2'-(all-cis-4,7,10,13,16,19-docosahexaenoate)
Benzenepropanoic acid, β-(benzoylamino)-α-[[(4Z,7Z,10Z,13Z,16Z,19Z)-1-oxo-4,7,10,13,16,19-docosahexaen-1-yl]oxy]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod...
應(yīng)用領(lǐng)域
用途一
DHA-Paclitaxel is a fatty acid derivative of Paclitaxel (P132500), an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi''s sarcoma.